Showing results (141-150 of 231) with videos related to
Sort By:
Pageof 24
The Journal of Veterinary Medical Science|September 27, 2016
Assessment of severity and changes in C-reactive protein concentration and various biomarkers in dogs with pancreatitisToru Sato, Koichi Ohno, Takashi Tamamoto, et al.Veterinary Journal (London, England : 1997)|June 25, 2016
Minimal residual disease in canine lymphoma: An objective marker to assess tumour cell burden in remissionMasahiko Sato, Jumpei Yamazaki, Yuko Goto-Koshino, et al.The Journal of Veterinary Medical Science|February 14, 2014
Prognostic analyses on anatomical and morphological classification of feline lymphomaHirofumi Sato, Yasuhito Fujino, Junko Chino, et al.Veterinary Immunology and Immunopathology|April 28, 2015
Association between lymphocyte antigen receptor gene rearrangements and histopathological evaluation in canine chronic enteropathySaaya Hiyoshi, Koichi Ohno, Kazuyuki Uchida, et al.Journal of Occupational Health|February 9, 2023
Multi-organ carcinogenicity by inhalation exposure to 2-Bromopropane in ratsHideki Senoh, Tatsuya Kasai, Shigeyuki Hirai, et al.Pain|October 9, 2019
A randomized controlled trial of 5 daily sessions and continuous trial of 4 weekly sessions of repetitive transcranial magnetic stimulation for neuropathic painKoichi Hosomi, Kenji Sugiyama, Yusaku Nakamura, et al.Veterinary Journal (London, England : 1997)|December 25, 2013
Prognostic significance of the expression levels of the p16, p15, and p14 genes in dogs with high-grade lymphomaAki Fujiwara-Igarashi, Yuko Goto-Koshino, Masahiko Sato, et al.The Journal of Veterinary Medical Science|February 19, 2016
Detection of circulating tumor cells using GeneScan analysis for antigen receptor gene rearrangements in canine lymphoma patientsSaaya Hiyoshi-Kanemoto, Yuko Goto-Koshino, Kenjiro Fukushima, et al.The Journal of Veterinary Medical Science|January 22, 2019
The intratumor heterogeneity of TP53 gene mutations in canine histiocytic sarcomaHajime Asada, Osamu Ichii, Hirotaka Tomiyasu, et al.Plos One|May 11, 2017
Hypoxia-activated prodrug TH-302 decreased survival rate of canine lymphoma cells under hypoxic conditionHiroki Yamazaki, Yu-Chang Lai, Morihiro Tateno, et al.Pageof 24